Training Coordinator (2nd Shift: 2:30pm-11pm)
AbbVie
Summary
Act as central point of contact for plant employees in coordinating and supporting the completion of training programs that are required to meet cGMP requirements.
Job description
Responsibilities
- Review of training records for completion and adherence to documentation practices and data entry of training records
- Verify accuracy of training records and documentation such as operating procedures, lab modules, training plant, curriculum vitae and certifications
- Maintain and revise Corporate Records retention schedules for department training records, training modules, and employee files
- Coordinate and schedule Instructor Led Training (ILT) and instructors
- Act as Learning Management System (LMS) database administrator
- Delivery of basic training materials such as cGMP, documentation practices, and new employee orientation
- Assist with the development of training materials
- Generate training reports to maintain and demonstrate compliance
- Prepare and participate in both internal and external training/compliance audits
- Compile and present training compliance metrics
Requirements
- High School diploma or GED equivalent is required
- Associate Degree or Bachelor's Degree in related field is desirable
- 1-2 years experience as a training coordinator or equivalent
- Certified as train-the-trainer is desirable
- Must be well organized and have excellent attention to detail
- Experience working in an environment regulated by FDA compliance and required documentation
- Knowledge of compliance and quality systems is required
- Good verbal and written communication skills
- Must possess and demonstrate the ability to prioritize multiple tasks and work under minimal supervision
Benefits
- Paid Time Off
- Medical, Dental & Vision Insurance
- 401(k)
- Short-Term Incentive Programs
Company overview
AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.